(ENOR) iShares MSCI Norway - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46429B4995 • Miscellaneous Region

ENOR: Securities, Stocks, Equity, Norway Market, Capitalization-Weighted

The iShares MSCI Norway ETF (BATS:ENOR) is designed to track the performance of the MSCI Norway Index, a free float-adjusted, market capitalization-weighted index that captures the large-, mid-, and small-cap segments of the Norwegian equity market. The fund typically invests at least 80% of its assets in securities from the underlying index or in investments with similar economic characteristics. This approach allows the ETF to closely replicate the indexs performance while maintaining flexibility in its investment strategy. As a non-diversified fund, ENOR can concentrate its holdings in a smaller number of securities, which may amplify both returns and risks. The fund is listed on the BATS exchange and is categorized under Miscellaneous Region ETFs.

From a technical standpoint, ENOR has shown recent strength, with its last price of $24.72 exceeding its 20-day and 50-day simple moving averages (SMAs) of $23.90 and $23.48, respectively. However, it remains slightly below its 200-day SMA of $23.61, indicating some longer-term instability. The average true range (ATR) of 0.26 suggests relatively low volatility, while the average 20-day volume of 6,926 shares reflects modest trading activity. Fundamentally, the ETF manages assets under management (AUM) of $28.80 million, which is moderate for a country-specific ETF but sufficient to ensure liquidity and operational efficiency.

3-Month Forecast (Based on Technical and Fundamental Data):

Over the next three months, ENOR is likely to experience low volatility, as indicated by its ATR of 0.26. The funds recent price movement above its 20-day and 50-day SMAs suggests potential short-term upside, though its position below the 200-day SMA may signal longer-term challenges. With moderate AUM and average daily trading volume, price movements could be influenced by shifts in global sentiment toward Norwegian equities, particularly in the energy and financial sectors, which are heavily represented in the MSCI Norway Index. Overall, the forecast is neutral with a slight positive bias, contingent on broader market conditions and Norways macroeconomic environment.

Additional Sources for ENOR ETF

ENOR ETF Overview

Market Cap in USD 36m
Category Miscellaneous Region
TER 0.53%
IPO / Inception 2012-01-23

ENOR ETF Ratings

Growth Rating 35.1
Fundamental -
Dividend Rating 76.8
Rel. Strength 1.13
Analysts -
Fair Price Momentum 25.25 USD
Fair Price DCF -

ENOR Dividends

Dividend Yield 12m 5.72%
Yield on Cost 5y 9.99%
Annual Growth 5y 18.81%
Payout Consistency 81.8%

ENOR Growth Ratios

Growth Correlation 3m 50.9%
Growth Correlation 12m 19.4%
Growth Correlation 5y 21.9%
CAGR 5y 12.70%
CAGR/Max DD 5y 0.39
Sharpe Ratio 12m 1.72
Alpha 3.07
Beta 0.718
Volatility 24.15%
Current Volume 13.2k
Average Volume 20d 12k
What is the price of ENOR stocks?
As of May 10, 2025, the stock is trading at USD 25.83 with a total of 13,170 shares traded.
Over the past week, the price has changed by +1.53%, over one month by +16.94%, over three months by +8.35% and over the past year by +11.90%.
Is iShares MSCI Norway a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares MSCI Norway (BATS:ENOR) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.13 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENOR as of May 2025 is 25.25. This means that ENOR is currently overvalued and has a potential downside of -2.25%.
Is ENOR a buy, sell or hold?
iShares MSCI Norway has no consensus analysts rating.
What are the forecast for ENOR stock price target?
According to ValueRays Forecast Model, ENOR iShares MSCI Norway will be worth about 28.2 in May 2026. The stock is currently trading at 25.83. This means that the stock has a potential upside of +9.21%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 28.2 9.2%